Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 6.290
- -0.230-3.53%
Close Dec 18 16:00 ET
- 6.280
- -0.010-0.16%
Pre 08:00 ET
45.89MMarket Cap-0.48P/E (TTM)
6.534High6.240Low66.43KVolume6.500Open6.520Pre Close423.38KTurnover1.46%Turnover RatioLossP/E (Static)7.30MShares11.35052wk High0.34P/B28.58MFloat Cap5.20252wk Low--Dividend TTM4.54MShs Float363.268Historical High--Div YieldTTM4.52%Amplitude5.200Historical Low6.373Avg Price1Lot Size
About Kezar Life Sciences Company
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.
Company Profile
SymbolKZR
Company NameKezar Life Sciences
Listing DateJun 21, 2018
Issue Price15.00
Founded2015
CEODr. Christopher Kirk, PhD
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
Address4000 Shoreline Court,Suite 300
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-822-5600
Company Executives
- Name
- Position
- Salary
- Dr. Christopher Kirk, PhD
- Director and Chief Executive Officer
- 2.60M
- Mark C. Schiller
- Chief Legal Officer
- --
- Marc L. Belsky
- Chief Financial Officer and Secretary
- 2.01M
- Graham K. Cooper
- Chairman of the Board
- 194.56K
- John Franklin Fowler
- Director
- 4.83M
- Courtney Wallace
- Independent Director
- 164.59K
- Dr. Micki Klearman, M.D.
- Independent Director
- 161.58K
- Franklin M. Berger, C.F.A.
- Independent Director
- 141.22K
- Dr. Elizabeth Garner, M.D.
- Independent Director
- 149.45K
- Dr. Michael Glen Kauffman, M.D.,PhD
- Independent Director
- 155.34K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.